Stockreport

BRIEF-Stemline Therapeutics Reports Q1 Loss Per Share $0.69 [Reuters]

STEMLINE THERAPEUTICS  (STML) 
Last stemline therapeutics earnings: 3/13 04:45 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.stemline.com/investor-relations
PDF BRIEF-Stemline Therapeutics Reports Q1 Loss Per Share $0.69 | Reuters Reuters Staff 1 Min Read May 9 (Reuters) - Stemline Therapeutics Inc: * STEMLINE THERAPEUTICS REPOR [Read more]